PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial
Introduction Tuberculosis (TB) continues to be one of the deadliest infectious diseases over the centuries, killing more people worldwide than any other single infectious disease. There is an urgent need for additional strategies which can expedite efforts to combat TB including a preventive vaccine...
Saved in:
Similar Items
Similar Items
-
Temporal pattern and effect of COVID-19 on the trend of TB, DRTB, paediatrics TB and TB with HIV Coinfection: A decadal trend analysis
by: Pushpendra Bairwa, et al.
Published: (2024-12-01) -
Accelerating TB regimen development: introducing FAST-TB
by: T. Devezin, et al.
Published: (2024-11-01) -
Challenges and Barriers Faced by People with TB and Healthcare Workers Providing TB Care and Management – A Qualitative Study
by: S. Suseendar, et al.
Published: (2024-04-01) -
Applying ‘timeliness’ to the screening and prevention of TB in household contacts of pulmonary TB patients
by: A. D. Harries, et al.
Published: (2024-02-01) -
More is needed to end TB: commentary on the United Nations High-Level Meeting on TB
by: G. B. Migliori, et al.
Published: (2024-01-01)